3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
19
Lung Neoplasms
16
Prostatic Neoplasms
12
Colorectal Neoplasms
12
Hematologic Neoplasms
7
Hematopoietic and Lymphatic System Neoplasm
6
Neoplasms
5
Neoplasm Metastasis
5
Lymphoma
5
Ovarian Neoplasms
4
Obesity-Related Malignant Neoplasm
4
Melanoma
4
Carcinoma, Non-Small-Cell Lung
4
Triple Negative Breast Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Pancreatic Neoplasms
3
Multiple Myeloma
3
Fatigue
3
Anatomic Stage I Breast Cancer AJCC v8
3
Advanced Malignant Solid Neoplasm
3
Uterine Cervical Neoplasms
2
Skin Carcinoma
2
Papillomavirus Infections
2
Malignant Solid Neoplasm
2
Lymphoma, Follicular
2
Leukemia, Myeloid, Acute
2
Hematopoietic and Lymphoid System Neoplasm
2
Healthy Subject
2
Genital Neoplasms, Female
2
Gastrointestinal Neoplasms
2
Interventions
pembrolizumab
5
Nivolumab
3
durvalumab
2
tremelimumab
1
relatlimab
1
fludarabine phosphate
1
fludarabine
1
avelumab
1
atezolizumab
1
Therapeutics
1
Temozolomide
1
Surgical Procedures, Operative
1
Neoadjuvant Therapy
1
Ipilimumab
1
Injections
1
Docetaxel
1
Cyclophosphamide
1
Chemotherapy, Adjuvant
1
Bevacizumab
1
ALT-803
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Microsatellite Instability
×
Educational Status
×
1 year
×
Clear all
No trials found.